0001209191-17-050805.txt : 20170830
0001209191-17-050805.hdr.sgml : 20170830
20170830190312
ACCESSION NUMBER: 0001209191-17-050805
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170829
FILED AS OF DATE: 20170830
DATE AS OF CHANGE: 20170830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayes William B
CENTRAL INDEX KEY: 0001320940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37837
FILM NUMBER: 171061765
MAIL ADDRESS:
STREET 1: 231 MAPLE AVENUE
CITY: BURLINGTON
STATE: NC
ZIP: 27215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Patheon N.V.
CENTRAL INDEX KEY: 0001643848
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981153534
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: EVERT VAN DE BEEKSTRAAT 104
CITY: AMSTERDAM SCHIPHOL
STATE: P7
ZIP: 1118 CN
BUSINESS PHONE: 31 (20) 622-3243
MAIL ADDRESS:
STREET 1: EVERT VAN DE BEEKSTRAAT 104
CITY: AMSTERDAM SCHIPHOL
STATE: P7
ZIP: 1118 CN
FORMER COMPANY:
FORMER CONFORMED NAME: Patheon Holdings Cooperatief U.A.
DATE OF NAME CHANGE: 20150601
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-29
1
0001643848
Patheon N.V.
PTHN
0001320940
Hayes William B
C/O PATHEON N.V.
EVERT VAN DE BEEKSTRAAT 104
AMSTERDAM SCHIPHOL
P7
1118 CN
NETHERLANDS
1
0
0
0
Restricted Stock Units (Ordinary Shares)
2017-08-29
4
U
0
17447
35.00
D
0
D
Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2)
upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3)
The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer.
This amount includes 6,229 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer.
/s/ Eric M. Sherbet, Attorney-In-Fact
2017-08-30